Palmdelphin Regulates Nuclear Resilience to Mechanical Stress in the Endothelium.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
16 11 2021
Historique:
pubmed: 13 10 2021
medline: 4 1 2022
entrez: 12 10 2021
Statut: ppublish

Résumé

PALMD (palmdelphin) belongs to the family of paralemmin proteins implicated in cytoskeletal regulation. Single nucleotide polymorphisms in the Immunodetection and public database screening showed dominant expression of PALMD in endothelial cells (ECs) in brain and cardiovascular tissues including aortic valves. Mass spectrometry, coimmunoprecipitation, and immunofluorescent staining allowed identification of PALMD partners. The consequence of loss of PALMD expression was assessed in small interferring RNA-treated EC cultures, knockout mice, and human valve samples. RNA sequencing of ECs and transcript arrays on valve samples from an aortic valve study cohort including patients with the single nucleotide polymorphism rs7543130 informed about gene regulatory changes. ECs express the cytosolic We identify RANGAP1 as a PALMD partner in ECs. Disrupting the PALMD/RANGAP1 complex alters the subcellular localization of RANGAP1 and XPO1, and leads to nuclear arrest of the XPO1 cargoes p53 and p21, accompanied by gene regulatory changes and loss of actin-dependent nuclear resilience. Combined, these consequences of reduced

Sections du résumé

BACKGROUND
PALMD (palmdelphin) belongs to the family of paralemmin proteins implicated in cytoskeletal regulation. Single nucleotide polymorphisms in the
METHODS
Immunodetection and public database screening showed dominant expression of PALMD in endothelial cells (ECs) in brain and cardiovascular tissues including aortic valves. Mass spectrometry, coimmunoprecipitation, and immunofluorescent staining allowed identification of PALMD partners. The consequence of loss of PALMD expression was assessed in small interferring RNA-treated EC cultures, knockout mice, and human valve samples. RNA sequencing of ECs and transcript arrays on valve samples from an aortic valve study cohort including patients with the single nucleotide polymorphism rs7543130 informed about gene regulatory changes.
RESULTS
ECs express the cytosolic
CONCLUSIONS
We identify RANGAP1 as a PALMD partner in ECs. Disrupting the PALMD/RANGAP1 complex alters the subcellular localization of RANGAP1 and XPO1, and leads to nuclear arrest of the XPO1 cargoes p53 and p21, accompanied by gene regulatory changes and loss of actin-dependent nuclear resilience. Combined, these consequences of reduced

Identifiants

pubmed: 34636652
doi: 10.1161/CIRCULATIONAHA.121.054182
pmc: PMC8589083
doi:

Substances chimiques

Membrane Proteins 0
PALMD protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1629-1645

Références

Dev Cell. 2009 Nov;17(5):617-25
pubmed: 19922867
Cell. 2002 Jan 11;108(1):83-96
pubmed: 11792323
J Cell Biol. 1998 Feb 9;140(3):499-509
pubmed: 9456312
Curr Med Chem. 2008;15(26):2648-55
pubmed: 18991627
Nat Commun. 2018 Mar 7;9(1):987
pubmed: 29511194
PLoS One. 2012;7(7):e41850
pubmed: 22855693
Nat Commun. 2016 Mar 15;7:10997
pubmed: 26975831
Front Cell Dev Biol. 2020 May 26;8:345
pubmed: 32528950
Atherosclerosis. 2018 Oct;277:60-65
pubmed: 30173080
Soft Matter. 2013 Jun 21;9(23):5516-5523
pubmed: 23930135
J Cell Physiol. 2011 Oct;226(10):2586-94
pubmed: 21792916
Nat Rev Dis Primers. 2016 Mar 03;2:16006
pubmed: 27188578
Elife. 2015 Dec 17;4:
pubmed: 26673895
Eur J Cell Biol. 2005 Nov;84(11):853-66
pubmed: 16323283
Int J Mol Sci. 2020 Nov 04;21(21):
pubmed: 33158204
Nat Commun. 2020 Sep 24;11(1):4828
pubmed: 32973141
J Cell Sci. 2012 Jul 1;125(Pt 13):3061-73
pubmed: 22797927
Commun Biol. 2020 Aug 28;3(1):477
pubmed: 32859967
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19017-22
pubmed: 19850871
Prog Mol Biol Transl Sci. 2014;126:205-15
pubmed: 25081619
Cold Spring Harb Perspect Biol. 2010 Aug;2(8):a000935
pubmed: 20679336
Circulation. 2011 Mar 29;123(12):1316-25
pubmed: 21403093
J Vis Exp. 2010 Dec 29;(46):
pubmed: 21248687
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Annu Rev Cell Dev Biol. 2020 Oct 6;36:85-114
pubmed: 32692592
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Cell. 2002 Jan 11;108(1):97-107
pubmed: 11792324
Sci Rep. 2017 Feb 02;7:41608
pubmed: 28148961
Clin Cancer Res. 2017 Mar 15;23(6):1552-1563
pubmed: 27649553
Int J Mol Sci. 2019 Mar 25;20(6):
pubmed: 30934548
Cell Adh Migr. 2011 Mar-Apr;5(2):170-80
pubmed: 21178402
J Cell Sci. 2018 Nov 21;131(22):
pubmed: 30333137
iScience. 2021 Feb 27;24(3):102241
pubmed: 33748722
Biomaterials. 2015 Oct;67:129-36
pubmed: 26210179
J Cell Sci. 2012 Apr 15;125(Pt 8):1855-64
pubmed: 22544950
Cells. 2019 Mar 11;8(3):
pubmed: 30862117
Cell Death Dis. 2014 May 08;5:e1221
pubmed: 24810057
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2587-91
pubmed: 8146159
Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8488-93
pubmed: 24889604
Cell Stem Cell. 2019 Apr 4;24(4):535-550.e9
pubmed: 30905618
Nature. 2018 Oct;562(7727):367-372
pubmed: 30283141
J Cardiol. 2020 Feb;75(2):124-133
pubmed: 31416779
Circ Genom Precis Med. 2019 Oct;12(10):e002617
pubmed: 32141789
Compr Physiol. 2019 Mar 15;9(2):873-904
pubmed: 30873580
Lancet. 2006 Sep 16;368(9540):1005-11
pubmed: 16980116
Ann Thorac Surg. 2003 Feb;75(2):457-65; discussion 465-6
pubmed: 12607654
Biochem Biophys Res Commun. 2008 Oct 3;374(4):609-13
pubmed: 18656442
J Biochem. 1992 Oct;112(4):503-7
pubmed: 1491005
Nat Commun. 2018 Mar 7;9(1):988
pubmed: 29511167

Auteurs

Miguel Sáinz-Jaspeado (M)

Rudbeck, Beijer and SciLifeLab Laboratories, Department of Immunology, Genetics and Pathology (M.S.-J., R.O.S., Y.J., S.N., Y.D., P.A., M.H., L.C.-W.), Uppsala University, Sweden.

Ross O Smith (RO)

Rudbeck, Beijer and SciLifeLab Laboratories, Department of Immunology, Genetics and Pathology (M.S.-J., R.O.S., Y.J., S.N., Y.D., P.A., M.H., L.C.-W.), Uppsala University, Sweden.

Oscar Plunde (O)

Department of Medicine Solna, Karolinska Institutet and Department of Cardiology, Karolinska University Hospital Stockholm, Sweden (O.P., S.-C.P., M.B.).

Sven-Christian Pawelzik (SC)

Department of Medicine Solna, Karolinska Institutet and Department of Cardiology, Karolinska University Hospital Stockholm, Sweden (O.P., S.-C.P., M.B.).

Yi Jin (Y)

Rudbeck, Beijer and SciLifeLab Laboratories, Department of Immunology, Genetics and Pathology (M.S.-J., R.O.S., Y.J., S.N., Y.D., P.A., M.H., L.C.-W.), Uppsala University, Sweden.

Sofia Nordling (S)

Rudbeck, Beijer and SciLifeLab Laboratories, Department of Immunology, Genetics and Pathology (M.S.-J., R.O.S., Y.J., S.N., Y.D., P.A., M.H., L.C.-W.), Uppsala University, Sweden.

Yindi Ding (Y)

Rudbeck, Beijer and SciLifeLab Laboratories, Department of Immunology, Genetics and Pathology (M.S.-J., R.O.S., Y.J., S.N., Y.D., P.A., M.H., L.C.-W.), Uppsala University, Sweden.

Pontus Aspenström (P)

Rudbeck, Beijer and SciLifeLab Laboratories, Department of Immunology, Genetics and Pathology (M.S.-J., R.O.S., Y.J., S.N., Y.D., P.A., M.H., L.C.-W.), Uppsala University, Sweden.

Marie Hedlund (M)

Rudbeck, Beijer and SciLifeLab Laboratories, Department of Immunology, Genetics and Pathology (M.S.-J., R.O.S., Y.J., S.N., Y.D., P.A., M.H., L.C.-W.), Uppsala University, Sweden.

Giulia Bastianello (G)

IFOM-FIRC (institute of molecular oncology - Fondazione italiana per la ricerca sul cancro), Milano, Italy (G.B., F.A., Q.L., M.F.).
University of Milan, Italy (G.B., M.F.).

Flora Ascione (F)

IFOM-FIRC (institute of molecular oncology - Fondazione italiana per la ricerca sul cancro), Milano, Italy (G.B., F.A., Q.L., M.F.).

Qingsen Li (Q)

IFOM-FIRC (institute of molecular oncology - Fondazione italiana per la ricerca sul cancro), Milano, Italy (G.B., F.A., Q.L., M.F.).

Cansaran Saygili Demir (CS)

Department of Oncology, University of Lausanne, Switzerland (C.S.D., T.V.P.).
Ludwig Institute for Cancer Research Lausanne, Switzerland (C.S.D., T.V.P.).

Dinesh Fernando (D)

Department of Forest Biomaterials and Technology, Swedish University of Agricultural Sciences, Uppsala (D.F., G.D.).

Geoffrey Daniel (G)

Department of Forest Biomaterials and Technology, Swedish University of Agricultural Sciences, Uppsala (D.F., G.D.).

Anders Franco-Cereceda (A)

Department of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Cardiothoracic Surgery, Karolinska University Hospital, Stockholm, Sweden (A.F.-C.).

Jeffrey Kroon (J)

Department of Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam University Medical Center, The Netherlands (J.K.).

Marco Foiani (M)

IFOM-FIRC (institute of molecular oncology - Fondazione italiana per la ricerca sul cancro), Milano, Italy (G.B., F.A., Q.L., M.F.).
University of Milan, Italy (G.B., M.F.).

Tatiana V Petrova (TV)

Department of Oncology, University of Lausanne, Switzerland (C.S.D., T.V.P.).
Ludwig Institute for Cancer Research Lausanne, Switzerland (C.S.D., T.V.P.).

Manfred W Kilimann (MW)

Department of Neuroscience (M.W.K.), Uppsala University, Sweden.
Department of Molecular Neurobiology, Max Planck Institute for Experimental Medicine, Göttingen, Germany (M.W.K.).

Magnus Bäck (M)

Department of Medicine Solna, Karolinska Institutet and Department of Cardiology, Karolinska University Hospital Stockholm, Sweden (O.P., S.-C.P., M.B.).

Lena Claesson-Welsh (L)

Rudbeck, Beijer and SciLifeLab Laboratories, Department of Immunology, Genetics and Pathology (M.S.-J., R.O.S., Y.J., S.N., Y.D., P.A., M.H., L.C.-W.), Uppsala University, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH